Breaking News Instant updates and real-time market news.

IOVA

Iovance Biotherapeutics

$18.21

0.21 (1.17%)

16:16
09/30/19
09/30
16:16
09/30/19
16:16

Iovance Biotherapeutics initiated with a Buy at Stifel

Stifel analyst Benjamin Burnett started Iovance Biotherapeutics with a Buy rating and $27 price target. The analyst says his physician checks corroborate the view that the company's lifileucel and LN-145 data are "very good" and supportive of being the best therapeutic option in their respective advanced settings. He believes the market opportunity for an autologous tumor-infiltrating lymphocyte product in the advanced melanoma/cervical cancer setting can reach $2B-plus sales at peak.

  • 02

    Oct

IOVA Iovance Biotherapeutics
$18.21

0.21 (1.17%)

06/28/19
PIPR
06/28/19
NO CHANGE
Target $30
PIPR
Overweight
Iovance Biotherapeutics price target raised to $30 from $20 at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro raised his price target for Iovance Biotherapeutics to $30 from $20 after spending two days hosting investor meetings with management. The analyst came away optimistic on a near term favorable regulatory update in cervical cancer. The FDA will, at minimum, accept some subset of the current cohort, which would allow enrollment to complete by the end of 2019 and a filing to occur ahead of the planned late-2020 melanoma submission, Catanzaro tells investors in a research note. As a result, he pushed U.S. cervical revenue into 2021. The analyst keeps an Overweight rating on shares of Iovance.
07/02/19
PIPR
07/02/19
NO CHANGE
Target $30
PIPR
Overweight
Iovance submission on track for second half of 2020, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro says guidance from the FDA, as announced this morning by the company, puts Iovance Biotherapeutics on track for a Biologics License Application in cervical cancer in the second half of 2020. This is a positive outcome and largely in-line with where consensus has moved following the ASCO presentation, Catanzaro tells investors in a research note. He maintains an Overweight rating on Iovance Biotherapeutics with a $30 price target.
07/02/19
HCWC
07/02/19
NO CHANGE
Target $32
HCWC
Buy
H.C. Wainwright reiterates Buy, $32 price target on Iovance
H.C. Wainwright analyst Joseph Pantginis reiterates a Buy rating on Iovance Biotherapeutics with a $32 price target after the company disclosed updates regarding the regulatory path for LN-145 in cervical cancer. With the possibility for innovaTIL-04 study to be registrational, the company is "reasonably" planning a path for a Biologics License Application submission in the second half of 2020, Pantginis tells investors in a research note. The analyst believes LN-145 "deserves the attention it is receiving." While the primary focus remains on Iovance's initial path to market with lifileucel in melanoma, LN-145 is a "potential rapid follower to commercialization," says Pantginis.
08/26/19
JEFF
08/26/19
NO CHANGE
Target $33
JEFF
Buy
Iovance pullback brings buying opportunity, says Jefferies
Jefferies analyst Biren Amin views the recent pullback in shares of Iovance Biotherapeutics as a buying opportunity into the end of 2019. After meeting with management, the analyst believes the melanoma and cervical pivotal cohorts appear to be enrolling patients with Iovance on track toward finishing patient enrollment in the melanoma study in Q1 of 2020. He thinks there is some likelihood of data at SITC in November and keeps a Buy rating on the shares with a $33 price target.

TODAY'S FREE FLY STORIES

MTNB

Matinas BioPharma

$0.90

(0.00%)

, AMRN

Amarin

$21.49

(0.00%)

09:52
11/14/19
11/14
09:52
11/14/19
09:52
Recommendations
Matinas BioPharma, Amarin analyst commentary  »

Amarin AdCom for Vascepa…

MTNB

Matinas BioPharma

$0.90

(0.00%)

AMRN

Amarin

$21.49

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

09:50
11/14/19
11/14
09:50
11/14/19
09:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD is…

09:48
11/14/19
11/14
09:48
11/14/19
09:48
Conference/Events
Federal Reserve Bank of St. Louis president speaks at a luncheon »

St. Louis Federal Reserve…

LOGM

LogMeln

$69.25

-0.31 (-0.45%)

09:48
11/14/19
11/14
09:48
11/14/19
09:48
Periodicals
LogMeln on watch with 'occasional activist' already involved, Dealreporter says »

Amid 13F filings coming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NTAP

NetApp

$59.71

-0.33 (-0.55%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Recommendations
NetApp analyst commentary  »

NetApp price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 12

    Dec

APHA

Aphria

$4.19

-0.27 (-6.05%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Aphria falls -6.1% »

Aphria is down -6.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZH

Beazer Homes

$13.51

-1.16 (-7.91%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Beazer Homes falls -7.3% »

Beazer Homes is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$16.01

-2.51 (-13.55%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Canopy Growth falls -13.4% »

Canopy Growth is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

PING

Ping Identity

$20.26

3.76 (22.79%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Ping Identity rises 23.2% »

Ping Identity is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

DDS

Dillard's

$81.00

13.2 (19.47%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Dillard's rises 19.5% »

Dillard's is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFF

Griffon

$25.45

3.73 (17.17%)

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Hot Stocks
Griffon rises 15.3% »

Griffon is up 15.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:47
11/14/19
11/14
09:47
11/14/19
09:47
Conference/Events
Federal Reserve Bank of Dallas president delivers opening remarks at a forum »

Dallas Federal Reserve…

BLMN

Bloomin' Brands

$23.20

0.01 (0.04%)

, INST

Instructure

$50.46

(0.00%)

09:45
11/14/19
11/14
09:45
11/14/19
09:45
Hot Stocks
Jana added Bloomin' Brands and Instructure during Q3, sold Falcon Minerals »

Barry Rosenstein's…

BLMN

Bloomin' Brands

$23.20

0.01 (0.04%)

INST

Instructure

$50.46

(0.00%)

FLMN

Falcon Minerals

$6.37

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$308.73

-0.35 (-0.11%)

ZBH

Zimmer Biomet

$144.50

(0.00%)

AXTA

Axalta Coating

$29.58

-0.07 (-0.24%)

HDS

HD Supply

$40.47

(0.00%)

JACK

Jack in the Box

$84.98

0.48 (0.57%)

CAG

Conagra Brands

$28.26

-0.06 (-0.21%)

ELY

Callaway Golf

$20.50

-0.11 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 03

    Dec

  • 09

    Dec

09:45
11/14/19
11/14
09:45
11/14/19
09:45
Conference/Events
Federal Reserve Bank of San Francisco president delivers opening remarks »

San Francisco Federal…

09:45
11/14/19
11/14
09:45
11/14/19
09:45
General news
Breaking General news story  »

Federal Reserve Chairman…

09:45
11/14/19
11/14
09:45
11/14/19
09:45
General news
Breaking General news story  »

Federal Reserve Chairman…

AAL

American Airlines

$28.65

(0.00%)

09:44
11/14/19
11/14
09:44
11/14/19
09:44
Conference/Events
The Wings Club to hold a luncheon meeting »

The Wings Club of New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

09:43
11/14/19
11/14
09:43
11/14/19
09:43
Conference/Events
House Committee on the Budget »

The Committee holds a…

CIR

Circor

$41.86

(0.00%)

09:43
11/14/19
11/14
09:43
11/14/19
09:43
Conference/Events
Circor management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EPD

Enterprise Products

$26.50

(0.00%)

, KMI

Kinder Morgan

$20.35

(0.00%)

09:42
11/14/19
11/14
09:42
11/14/19
09:42
Conference/Events
Wolfe Research to hold a tour »

Houston Midstream Bus…

EPD

Enterprise Products

$26.50

(0.00%)

KMI

Kinder Morgan

$20.35

(0.00%)

PAA

Plains All American

$17.48

(0.00%)

RBN

Robbins & Myers

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 04

    Feb

CSGS

CSG

$56.29

(0.00%)

09:42
11/14/19
11/14
09:42
11/14/19
09:42
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

MTSI

Macom

$26.47

(0.00%)

09:41
11/14/19
11/14
09:41
11/14/19
09:41
Recommendations
Macom analyst commentary  »

Macom price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

HCSG

Healthcare Services

$24.88

(0.00%)

09:41
11/14/19
11/14
09:41
11/14/19
09:41
Conference/Events
Healthcare Services management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

WYND

Wyndham Destinations

$47.24

(0.00%)

, WYNN

Wynn Resorts

$118.86

(0.00%)

09:41
11/14/19
11/14
09:41
11/14/19
09:41
Conference/Events
Deutsche Bank to hold a conference »

Gaming, Lodging, Leisure…

WYND

Wyndham Destinations

$47.24

(0.00%)

WYNN

Wynn Resorts

$118.86

(0.00%)

WH

Wyndham Hotels & Resorts

$54.13

(0.00%)

WYN

Wyndham

$0.00

(0.00%)

VICI

VICI Properties

$24.34

(0.00%)

TH

Target Hospitality

$4.70

(0.00%)

INN

Summit Hotel Properties

$11.75

0.18 (1.56%)

SGMS

Scientific Games

$30.70

(0.00%)

RHP

Ryman Hospitality

$87.20

(0.00%)

RRR

Red Rock Resorts

$21.30

(0.00%)

RCL

Royal Caribbean

$114.81

(0.00%)

VAC

Marriott Vacations

$117.19

(0.00%)

MGM

MGM Resorts

$31.04

(0.00%)

NCLH

Norwegian Cruise Line

$52.11

(0.00%)

PENN

Penn National

$21.97

(0.00%)

AGS

PlayAGS

$11.66

(0.00%)

LVS

Las Vegas Sands

$62.15

(0.00%)

HLT

Hilton

$97.79

(0.00%)

GDEN

Golden Entertainment

$17.00

(0.00%)

GLPI

Gaming and Leisure Properties

$42.48

(0.00%)

FLL

Full House Resorts

$2.96

(0.00%)

STAY

Extended Stay America

$14.57

(0.00%)

ERI

Eldorado Resorts

$50.80

(0.00%)

DIN

Dine Brands

$79.06

(0.00%)

CPLG

CorePoint Lodging

$9.83

(0.00%)

CLDT

Chatham Lodging

$17.59

(0.00%)

FUN

Cedar Fair

$56.92

(0.00%)

BYD

Boyd Gaming

$29.05

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Nov

  • 02

    Dec

  • 05

    Dec

  • 09

    Dec

SKYW

SkyWest

$63.17

(0.00%)

09:40
11/14/19
11/14
09:40
11/14/19
09:40
Conference/Events
SkyWest management to meet with Sidoti »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.